Technical Assessment of an Automated Treatment Planning on Dose Escalation of Pancreas Stereotactic Body Radiotherapy

被引:4
|
作者
Wang, Shuo [1 ]
Zheng, Dandan [1 ]
Lin, Chi [1 ]
Lei, Yu [1 ]
Verma, Vivek [2 ]
Smith, April [1 ]
Ma, Rongtao [3 ]
Enke, Charles A. [1 ]
Zhou, Sumin [1 ]
机构
[1] Univ Nebraska, Dept Radiat Oncol, Med Ctr, Omaha, NE 68198 USA
[2] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA
[3] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, 1275 York Ave, New York, NY 10021 USA
关键词
stereotactic body radiotherapy; pancreatic cancer; automated treatment planning; dose escalation; personalized treatment; RADIATION-THERAPY SMART; ADAPTIVE RADIOTHERAPY; DE-ESCALATION; PHASE-II; CANCER; IMRT; RADIOSURGERY; GEMCITABINE; HEAD; ADENOCARCINOMA;
D O I
10.1177/1533033819851520
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Stereotactic body radiotherapy has been suggested to provide high rates of local control for locally advanced pancreatic cancer. However, the close proximity of highly radiosensitive normal tissues usually causes the labor-intensive planning process and may impede further escalation of the prescription dose. Purpose: The present study aims to evaluate the consistency and efficiency of Pinnacle Auto-Planning for pancreas stereotactic body radiotherapy with original prescription and escalated prescription. Methods: Twenty-four patients with pancreatic cancer treated with stereotactic body radiotherapy were studied retrospectively. The prescription is 40 Gy over 5 consecutive fractions. Most of patients (n = 21) also had 3 other different dose-level targets (6 Gy/fraction, 5 Gy/fraction, and 4 Gy/fraction). Two types of plans were generated by Pinnacle Auto-Planning with the original prescription (8 Gy/fraction, 6 Gy/fraction, 5 Gy/fraction, and 4 Gy/fraction) and escalated prescription (9 Gy/fraction, 7 Gy/fraction, 6 Gy/fraction, and 5 Gy/fraction), respectively. The same Auto-Planning template, including beam geometry, intensity-modulated radiotherapy objectives and intensity-modulated radiotherapy optimization parameters, were utilized for all the auto-plans in each prescription group. The intensity-modulated radiotherapy objectives do not include any manually created structures. Dosimetric parameters including percentage volume of PTV receiving 100% of the prescription dose, percentage volume of PTV receiving 93% of the prescription dose, and consistency of the dose-volume histograms of the target volumes were assessed. D-max and D-1 cc of highly radiosensitive organs were also evaluated. Results: For all the pancreas stereotactic body radiotherapy plans with the original or escalated prescriptions, auto-plans met institutional dose constraints for critical organs, such as the duodenum, small intestine, and stomach. Furthermore, auto-plans resulted in acceptable planning target volume coverage for all targets with different prescription levels. All the plans were generated in a one-attempt manner, and very little human intervention is necessary to achieve such plan quality. Conclusions: Pinnacle(3) Auto-Planning consistently and efficiently generate acceptable treatment plans for multitarget pancreas stereotactic body radiotherapy with or without dose escalation and may play a more important role in treatment planning in the future.
引用
收藏
页码:1 / 10
页数:10
相关论文
共 50 条
  • [1] Stereotactic Body Radiotherapy in the Treatment of Advanced Adenocarcinoma of the Pancreas
    Rwigema, Jean-Claude M.
    Parikh, Simul D.
    Heron, Dwight E.
    Howell, Michael
    Zeh, Herbert
    Moser, A. James
    Bahary, Nathan
    Quinn, Annette
    Burton, Steven A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (01): : 63 - 69
  • [2] Evaluation of Automated Treatment Planning and Organ Dose Prediction for Lung Stereotactic Body Radiotherapy
    Ouyang, Zi
    Zhuang, Tingliang
    Marwaha, Gaurav
    Kolar, Matthew D.
    Qi, Peng
    Videtic, Gregory M.
    Stephans, Kevin L.
    Xia, Ping
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [3] Dose escalation with stereotactic body radiotherapy for cervical cancer treatment
    Turna, Menekse
    Rzazade, Rashad
    Kucukmorkoc, Esra
    Kucuk, Nadir
    Canoglu, Mehmet Dogu
    Caglar, Hale Basak
    BMC CANCER, 2024, 24 (01)
  • [4] Stereotactic Body Radiotherapy (SBRT) Reirradiation for Recurrent Pancreas Cancer
    Dagoglu, Nergiz
    Callery, Mark
    Moser, James
    Tseng, Jennifer
    Kent, Tara
    Bullock, Andrea
    Miksad, Rebecca
    Mancias, Joseph D.
    Mahadevan, Anand
    JOURNAL OF CANCER, 2016, 7 (03): : 283 - 288
  • [5] Automated treatment planning for liver cancer stereotactic body radiotherapy
    He, Ling
    Peng, Xingchen
    Chen, Na
    Wei, Zhigong
    Wang, Jingjing
    Liu, Yingtong
    Xiao, Jianghong
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (11): : 3230 - 3240
  • [6] Automated treatment planning as a dose escalation strategy for stereotactic radiation therapy in pancreatic cancer
    Cilla, Savino
    Ianiro, Anna
    Romano, Carmela
    Deodato, Francesco
    Macchia, Gabriella
    Viola, Pietro
    Buwenge, Milly
    Cammelli, Silvia
    Pierro, Antonio
    Valentini, Vincenzo
    Morganti, Alessio G.
    JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS, 2020, 21 (11): : 48 - 57
  • [7] Assessment of semi-automated stereotactic treatment planning for online adaptive radiotherapy in ethos
    Byrne, Mikel
    Archibald-Heeren, Ben
    Hu, Yunfei
    Greer, Peter
    Luo, Suhuai
    Aland, Trent
    MEDICAL DOSIMETRY, 2022, 47 (04) : 342 - 347
  • [8] Failure patterns and outcomes of dose escalation of stereotactic body radiotherapy for locally advanced pancreatic cancer: a multicenter cohort study
    Zhu, Xiaofei
    Cao, Yangsen
    Su, Tingshi
    Zhu, Xixu
    Ju, Xiaoping
    Zhao, Xianzhi
    Jiang, Lingong
    Ye, Yusheng
    Cao, Fei
    Qing, Shuiwang
    Zhang, Huojun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [9] Stereotactic Body Radiotherapy in the Treatment of Pancreatic Cancer
    Trakul, Nicholas
    Koong, Albert C.
    Chang, Daniel T.
    SEMINARS IN RADIATION ONCOLOGY, 2014, 24 (02) : 140 - 147
  • [10] Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
    Goldsmith, Christy
    Plowman, P. Nicholas
    Green, Melanie M.
    Dale, Roger G.
    Price, Patricia M.
    RADIATION ONCOLOGY, 2018, 13